Signing Instruction for Language Development
What You Need to Know Before You Apply
What is the purpose of this trial?
Eight deaf children in kindergarten to 3rd grade classes will be randomly selected for single case research. Their language skills will be monitored and assessed daily. Using a noncurrent multiple baseline design (Single Case Research Design or SCRD), Strategic and Interactive Signing Instruction (SISI) will be administered to two children in each of four classes.
Do I need to stop my current medications for this trial?
The trial information does not specify whether participants need to stop taking their current medications.
How does the Strategic and Interactive Signing Instruction (SISI) treatment differ from other treatments for language development?
The Strategic and Interactive Signing Instruction (SISI) treatment is unique because it focuses on using sign language as a strategic and interactive tool to enhance language development, particularly for deaf and hard of hearing children. Unlike other treatments that may rely on verbal or written language, SISI emphasizes the use of gestures and signs to facilitate communication and cognitive processes, making it particularly effective in environments where conventional linguistic input is limited.12345
What data supports the effectiveness of the treatment Strategic and Interactive Signing Instruction (SISI) for language development?
Research shows that teaching sign language skills to caregivers and individuals with cognitive impairments can improve communication and social interactions. Studies have demonstrated that sign language training helps maintain learned skills over time and enhances social behaviors, suggesting that similar methods like SISI could be effective for language development.13678
Are You a Good Fit for This Trial?
This trial is for deaf children in kindergarten to 3rd grade. To participate, they must be randomly selected from their classes and have no other conditions that would affect the study's results.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Children remain in the baseline phase before receiving Strategic and Interactive Signing Instruction (SISI)
Treatment
Participants receive Strategic and Interactive Signing Instruction (SISI) and their language skills are monitored and assessed daily
Follow-up
Participants are monitored for the development of target sign language skills
What Are the Treatments Tested in This Trial?
Interventions
- Strategic and Interactive Signing Instruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator